Xiuli Zuo: Clinical Trials

10 trials sponsored by Xiuli Zuo, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 not yet recruiting, 4 unknown, 1 completed, 1 recruiting. 3 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable3Completed 1, Recruiting 1, Unknown 1

Follow Xiuli Zuo: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Artificial Intelligence-Based Automatic Recognition and Localization of Anatomical Sites in Colonoscopy
Artificial intelligence-based colonoscopic anatomical site recognition system - Colonic Diseases
Not yet recruitingXiuli Zuo80002026-10-012026-09-30
Multimodal Artificial Intelligence for Non-Invasive Colorectal Cancer Screening Based on Holographic Biology
Multimodal non-invasive detection for colorectal cancer - Colorectal Cancer
Not yet recruitingXiuli Zuo110002026-10-012026-09-11
Efficacy of Rifaximin in Patients With Small Intestinal Bacterial Overgrowth Presenting With Abdominal Bloating.
Rifaximin (drug) - SIBO
Not applicableRecruitingXiuli Zuo1152025-04-152025-05-16
Efficacy of a 14-Day Bismuth-Containing Quadruple Therapy Guided by Drug Susceptibility Testing in Patients with Extremely Refractory Helicobacter Pylori Infection: an Exploratory Study
Bismuth, Vonoprazan, Amoxicillin - HELICOBACTER PYLORI INFECTIONS
Not yet recruitingXiuli Zuo302025-01-012024-12-19
Observation on the Efficacy of Radiofrequency Ablation for Patients With Moderate to Severe Gastric Atrophy With Enterosis With or Without Atrophy of Intraepithelial Neoplasia: An Observational Study
Radiofrequency ablation alone - Atrophic Gastritis
Not yet recruitingXiuli Zuo622024-12-312024-12-27
Measurement and Analysis of Gas Composition in Digestive Tract
gas component of digestive tract - Inflammatory Bowel Diseases, Irritable Bowel Syndrome
UnknownXiuli Zuo4602023-04-012023-04-12
Efficacy and Safety of 14-day Concomitant Therapy for Difficult-to-Treat Helicobacter Pylori Infection
three kinds of antibiotics including amoxicillin,tetracycline, furazolidone, levofloxacin,clarithromycin,levofloxacin,tinidazole,metronidazol - Helicobacter Pylori Infection
Not applicableUnknownXiuli Zuo602021-11-202021-12-01
The Diversity of the Fungal and Bacterial in Colon Mucosa of Patients With Different Degree of Inflammation of Ulcerative Colitis
ulcerative colitis, Control - Ulcerative Colitis
UnknownXiuli Zuo502016-07-012017-05-12
Study on Correlated Factors of Barrier and Immune Function in Stress Related Mucosal Disease (SRMD)
Endoscopy biopsy and blood - Stress Related Mucosal Disease
Not applicableCompletedXiuli Zuo532016-01-012017-06-27
Artificial Intelligence for Determination of Gastroscopy Surveillance Intervals
AI recongnize disease and generate recommendations - Helicobacter Pylori Infection, Atrophic Gastritis
UnknownXiuli Zuo20002012-01-012022-11-30

Conditions studied

Colorectal Neoplasms (2)  ·  Gastritis, Atrophic (2)  ·  Colitis, Ulcerative (1)  ·  Colonic Diseases (1)  ·  Inflammatory Bowel Diseases (1)  ·  Irritable Bowel Syndrome (1)  ·  Stomach Neoplasms (1)

Interventions

1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine (1)  ·  Amoxicillin (1)  ·  Anti-Bacterial Agents (1)  ·  Bismuth (1)  ·  Blood Specimen Collection (1)  ·  Furazolidone (1)  ·  Levofloxacin (1)  ·  Metronidazole (1)  ·  Pharmaceutical Preparations (1)  ·  Radiofrequency Ablation (1)  ·  Rifabutin (1)  ·  Rifaximin (1)

Countries

China (7)

Results publications

PMID 23882266, PMID 25522934, PMID 26843508, PMID 41578770